Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Department of Neurology, Universitätsklinikum Schleswig-Holstein, Kiel Campus, Germany; Christian-Albrechts Universität, Kiel, Germany.
J Neurol Sci. 2018 Jun 15;389:55-60. doi: 10.1016/j.jns.2018.02.013. Epub 2018 Feb 5.
Among the broad entity of tardive syndromes, tardive dystonia and classical tardive dyskinesia sometimes require advanced treatments like deep brain stimulation of the globus pallidus internum (Gpi-DBS) or the subthalamic nucleus (STN-DBS). This systematic review has analyzed the currently available literature reporting cases with either tardive dystonia or dyskinesia treated with DBS. The key words for the literature search included all tardive syndromes and "deep brain stimulation." Thirty-four level VI studies and one level II study with 117 patients were included. Level I studies were not identified. Only four of the patients had tardive dyskinesia. All the others had tardive dystonia. The majority had Gpi-DBS (n = 109). Patients had a mean age of 47.4 (± SD 14.7) years. The duration of follow-up was 25.6 months ± 26.2. The Abnormal Involuntary Movement Scale was reported in 51 patients with an improvement of 62 ± 15% and the Burke-Fahn-Marsden scale was reported in 67 cases with an improvement of 76 ± 21%. Reported adverse events were surgery-related in 7 patients, stimulation-induced in 12, and psychiatric in 3 patients. These reports thus suggest favorable effects of DBS and it seems to be relatively safe. DBS can be considered for patients with severe, medication-resistant symptoms. Controlled and randomized studies with blinded outcomes are needed.
在广泛的迟发性综合征实体中,迟发性肌张力障碍和经典迟发性运动障碍有时需要先进的治疗方法,如苍白球 internum 内(Gpi-DBS)或丘脑底核(STN-DBS)的深部脑刺激。本系统评价分析了目前报道的使用 DBS 治疗迟发性肌张力障碍或运动障碍的病例的现有文献。文献检索的关键词包括所有迟发性综合征和“深部脑刺激”。纳入了 34 项 VI 级研究和 1 项 II 级研究共 117 例患者。未发现 I 级研究。只有 4 例患者患有迟发性运动障碍。其余均为迟发性肌张力障碍。大多数患者接受 Gpi-DBS(n=109)。患者平均年龄为 47.4(±SD 14.7)岁。随访时间为 25.6±26.2 个月。51 例患者报告了异常不自主运动量表,改善率为 62±15%,67 例患者报告了 Burke-Fahn-Marsden 量表,改善率为 76±21%。报告的不良事件有 7 例与手术相关,12 例与刺激相关,3 例与精神相关。这些报告表明 DBS 具有良好的效果,而且似乎相对安全。对于有严重、药物抵抗症状的患者,可以考虑使用 DBS。需要进行对照和随机研究,并采用盲法结局。